$4.3 million secured to commercialise Stroke Test
- Upfront Diagnostics
- May 12
- 2 min read
Updated: May 15
We are proud to announce our lead investment in Upfront Diagnostics, a pioneering medical technology company based in Cambridge, who have successfully raised $4.3 million in a recent funding round.
The funding will accelerate the commercialisation of Upfront’s groundbreaking stroke blood test, LVOne, in the UK and Europe and facilitate expansion into new international markets. The funding round also saw participation from Cambridge Enterprise Ventures, alongside non-dilutive funding from SBRI Healthcare.
The LVOne is a rapid, fingerstick blood test that can diagnose Large Vessel Occlusion (or LVO) strokes in just 15 minutes, from anywhere. LVO strokes are responsible for 95% of stroke deaths and disabilities.
The new funding will be used by Upfront Diagnostics to:
• Initiate the commercial launch of LVOne in the UK and across Europe.
• Support the necessary regulatory approval processes for entry into the US market.
• Further expand the company’s research and development capabilities to enhance their diagnostic technologies.
Gonzalo Ladreda, CEO of Upfront, expressed his enthusiasm for the company’s future, stating:
“This funding round is a significant milestone for Upfront. It will enable us to bring LVOne to market and make a real difference in the lives of stroke patients. We are grateful for the support of our investors and partners, and we look forward to continuing our mission to improve stroke diagnosis and treatment.”
Dr Tito Bacarese, Chairman of Upfront, expressed his pride in the team’s accomplishment, stating:
“The perseverance and innovative spirit demonstrated by Upfront’s team have been instrumental in securing this funding. This achievement is a testament to their unwavering dedication to revolutionizing the diagnostics landscape by providing elegant solutions for complex conditions. We are grateful to have the backing of a prestigious group like Phoenix Investments, whose support will enable Upfront to impact thousands of lives.”
Find out more about Upfront Diagnostics and their progress on their website.
Story by Upfront Daignostics
Комментарии